Secondary mechanisms of diversification in the human antibody repertoire

Por Briney, Bryan S., Jr., James E. Crowe
Publicado em 2013

Human-likeness of antibody biologics determined by back-translation and comparison with large antibody variable gene repertoires

Por Samuel Schmitz, Cinque Soto, James E. Crowe, Jens Meiler
Publicado em 2020-01-01

The human antibody sequence space and structural design of the V, J regions, and CDRH3 with Rosetta

Por Samuel Schmitz, Emily A. Schmitz, James E. Crowe, Jens Meiler
Publicado em 2022-12-01

Improving Loop Modeling of the Antibody Complementarity-Determining Region 3 Using Knowledge-Based Restraints.

Por Jessica A Finn, Julia Koehler Leman, Jordan R Willis, Alberto Cisneros, James E Crowe, Jens Meiler
Publicado em 2016-01-01

Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape

Por Naveenchandra Suryadevara, Pavlo Gilchuk, Seth J. Zost, Nikhil Mittal, Li Leyna Zhao, James E. Crowe, Jr., Robert H. Carnahan
Publicado em 2022-06-01

Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses.

Por Tshidi Tsibane, Damian C Ekiert, Jens C Krause, Osvaldo Martinez, James E Crowe, Ian A Wilson, Christopher F Basler
Publicado em 2012-01-01

PyIR: a scalable wrapper for processing billions of immunoglobulin and T cell receptor sequences using IgBLAST

Por Cinque Soto, Jessica A. Finn, Jordan R. Willis, Samuel B. Day, Robert S. Sinkovits, Taylor Jones, Samuel Schmitz, Jens Meiler, Andre Branchizio, James E. Crowe
Publicado em 2020-07-01

Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model.

Por Justin B Callaway, Scott A Smith, Douglas G Widman, Karen P McKinnon, Frank Scholle, Gregory D Sempowski, Dirk P Dittmer, James E Crowe, Aravinda M de Silva, Jenny P-Y Ting
Publicado em 2015-01-01

Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques.

Por Rebecca Broeckel, Julie M Fox, Nicole Haese, Craig N Kreklywich, Soila Sukulpovi-Petty, Alfred Legasse, Patricia P Smith, Michael Denton, Carsten Corvey, Shiv Krishnan, Lois M A Colgin, Rebecca M Ducore, Anne D Lewis, Michael K Axthelm, Marie Mandron, Pierre Cortez, Jonathan Rothblatt, Ercole Rao, Ingo Focken, Kara Carter, Gopal Sapparapau, James E Crowe, Michael S Diamond, Daniel N Streblow
Publicado em 2017-06-01